Ketanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Tapentadol | The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Tapentadol. |
| Citalopram | The risk or severity of bleeding can be increased when Ketanserin is combined with Citalopram. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Ketanserin. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Levomilnacipran. |
| Avanafil | Ketanserin may increase the hypotensive activities of Avanafil. |
| Venlafaxine | The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Venlafaxine. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Ketanserin. |
| Midazolam | The risk or severity of sedation and CNS depression can be increased when Midazolam is combined with Ketanserin. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ketanserin. |
| Trazodone | The risk or severity of bleeding can be increased when Trazodone is combined with Ketanserin. |
| Cyclobenzaprine | The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ketanserin. |
| Metoclopramide | The risk or severity of sedation can be increased when Metoclopramide is combined with Ketanserin. |
| Escitalopram | The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Escitalopram. |
| Quetiapine | Quetiapine may increase the hypotensive activities of Ketanserin. |
| Lasmiditan | The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Ketanserin. |
| Sertraline | The risk or severity of bleeding can be increased when Sertraline is combined with Ketanserin. |
| Tramadol | The risk or severity of CNS depression can be increased when Ketanserin is combined with Tramadol. |
| Ziprasidone | The risk or severity of adverse effects can be increased when Ketanserin is combined with Ziprasidone. |
| Cyclothiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Cyclothiazide. |
| Trichlormethiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Trichlormethiazide. |
| Polythiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Polythiazide. |
| Cyclopenthiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Cyclopenthiazide. |
| Methyclothiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Methyclothiazide. |
| Bendroflumethiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Bendroflumethiazide. |
| Hydroflumethiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Hydroflumethiazide. |
| Chlorothiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Chlorothiazide. |
| Hydrochlorothiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Hydrochlorothiazide. |
| Benzthiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Benzthiazide. |
| Mebutizide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Mebutizide. |
| Buthiazide | The therapeutic efficacy of Ketanserin can be increased when used in combination with Buthiazide. |
| Haloperidol | The risk or severity of CNS depression can be increased when Haloperidol is combined with Ketanserin. |
| Fluoxetine | The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Fluoxetine. |
| Indapamide | The therapeutic efficacy of Indapamide can be increased when used in combination with Ketanserin. |
| Fenfluramine | The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Fenfluramine. |
| Oliceridine | The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ketanserin is combined with Oliceridine. |
| Vortioxetine | The risk or severity of bleeding can be increased when Vortioxetine is combined with Ketanserin. |
| Serdexmethylphenidate | The therapeutic efficacy of Ketanserin can be decreased when used in combination with Serdexmethylphenidate. |
| Silodosin | The risk or severity of orthostatic hypotension and dizziness can be increased when Ketanserin is combined with Silodosin. |
| Ginkgo biloba | Ginkgo biloba may increase the antiplatelet activities of Ketanserin. |
| Ropeginterferon alfa-2b | The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Ketanserin. |
| Daridorexant | The risk or severity of CNS depression can be increased when Ketanserin is combined with Daridorexant. |
| Abrocitinib | The risk or severity of bleeding and thrombocytopenia can be increased when Ketanserin is combined with Abrocitinib. |
| Padeliporfin | The risk or severity of bleeding can be increased when Ketanserin is combined with Padeliporfin. |
| Sodium ferric gluconate complex | The risk or severity of hypotension can be increased when Sodium ferric gluconate complex is combined with Ketanserin. |
| Ganaxolone | The risk or severity of sedation, somnolence, and CNS depression can be increased when Ketanserin is combined with Ganaxolone. |
| Zuranolone | The risk or severity of CNS depression can be increased when Zuranolone is combined with Ketanserin. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Lisdexamfetamine. |
| Gepirone | The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Ketanserin. |
| Inotersen | The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Ketanserin. |
| Iloprost | Iloprost may increase the hypotensive activities of Ketanserin. |